103911561
commented on
Recently, $Novo-Nordisk A/S (NVO.US)$ (Novo Nordisk, NVO) The stock price has significantly risen, and the market focus is on itsstar drug Ozempic (semaglutide) 's cardiovascular trial results. If trial data confirms that the drug can reduce cardiovascular risk, it will bring potential market expansion for Novo Nordisk and impact competitors Eli Lilly (Eli Lilly and Co, LLY) The competitive landscape of the GLP-1 receptor agonist market. However, investors need to pay attention to the actual impact of this event onstock price valuation, regulatory approval, sales growth, and market risksto make rational investment decisions.For more dynamics and in-depth analysis of the US stock market, please follow "US Stocks 101" to grasp the latest investment opportunities!
How do the clinical trial results impact the market position of Novo-Nordisk A/S?
The goal of this cardiovascular trial is to test whether Ozempic can reduce cardiovascular risks in patients with diabetes and obesity. If the data proves that the drug can significantly reduce the risk of heart attacks, strokes, or other cardiovascular complications, then Ozempic will not only be a diabetes and weight-loss medication but will also enterCardiovascular treatment marketThis will significantly enhance its market value and may drive Insurance companies to increase the reimbursement ratio for this drug, continuing...
How do the clinical trial results impact the market position of Novo-Nordisk A/S?
The goal of this cardiovascular trial is to test whether Ozempic can reduce cardiovascular risks in patients with diabetes and obesity. If the data proves that the drug can significantly reduce the risk of heart attacks, strokes, or other cardiovascular complications, then Ozempic will not only be a diabetes and weight-loss medication but will also enterCardiovascular treatment marketThis will significantly enhance its market value and may drive Insurance companies to increase the reimbursement ratio for this drug, continuing...
Translated

5
1
1
103911561
commented on
$NVIDIA (NVDA.US)$ Today's NVIDIA makes me feel confused. A flood of bullish news, yet the stock price of such an excellent company is set to plummet. If this is the standard, is there any company worth investing in? If the best cannot make it, shouldn't other companies just be delisted?
Translated
3
3
$Novo-Nordisk A/S (NVO.US)$ The little prince of the pre-market is back again. 🤣
Translated
1
103911561
voted
$NVIDIA (NVDA.US)$
Jensen Huang, Founder and CEO of Nvidia, will deliver the keynote at GTC 2025. This event, scheduled for March 18 at 1:00 PM ET / March 19 at 1:00 AM SGT / March 19 at 4:00 AM AEST, will cover groundbreaking advancements in AI, digital twins, cloud technologies, and sustainable computing.
Huang's keynote will provide a visionary roadmap of Nvidia's role in shaping the AI-driven world. Subscribe to join the live NOW!
NVIDIA Stock Predicti...
Jensen Huang, Founder and CEO of Nvidia, will deliver the keynote at GTC 2025. This event, scheduled for March 18 at 1:00 PM ET / March 19 at 1:00 AM SGT / March 19 at 4:00 AM AEST, will cover groundbreaking advancements in AI, digital twins, cloud technologies, and sustainable computing.
Huang's keynote will provide a visionary roadmap of Nvidia's role in shaping the AI-driven world. Subscribe to join the live NOW!
NVIDIA Stock Predicti...

GTC Keynote With NVIDIA CEO Jensen Huang
Mar 19 01:00
430
330
65
103911561
commented on
$Apple (AAPL.US)$ do apple have 1.5 or 2x etf?
2
5
103911561
commented on
103911561
commented on
$Novo-Nordisk A/S (NVO.US)$
bullish side - scooping stop loss below 200ma and rebound for a breakout.
bearish side - coming back to retest 200ma faking a breakout.
bullish wise I believe entry is possible with stop losses at previous low.
I'm skipping nvo simply because I'm focusing on megacaps now lol. (megacaps are more stable).
I may join back when there's a clear breakout trend. have to check the charts again what's the possible measured move risk and reward.![]()
bullish side - scooping stop loss below 200ma and rebound for a breakout.
bearish side - coming back to retest 200ma faking a breakout.
bullish wise I believe entry is possible with stop losses at previous low.
I'm skipping nvo simply because I'm focusing on megacaps now lol. (megacaps are more stable).
I may join back when there's a clear breakout trend. have to check the charts again what's the possible measured move risk and reward.

3
1
103911561
commented on
$Novo-Nordisk A/S (NVO.US)$ many stocks are at ascending triangle while index is on descending triangle. very risky ![]()
5
103911561
commented on
$Vistra Energy (VST.US)$ reached my breakeven. uh.. not greedy. 20ma im out ty
3
11
103911561 :
It is about to fall to the bottom, yet it is rising significantly.